{
    "clinical_study": {
        "@rank": "102437", 
        "arm_group": [
            {
                "arm_group_label": "CR/CTR group", 
                "description": "The complete remission group treated by the Comprehensive Treatment Regimen"
            }, 
            {
                "arm_group_label": "NR/CTR group", 
                "description": "The non-remission group treated by the Comprehensive Treatment Regimen"
            }, 
            {
                "arm_group_label": "CR/IA group", 
                "description": "The complete remission group treated by Immunosuppressive Agents"
            }, 
            {
                "arm_group_label": "NR/IA group", 
                "description": "The non-remission group treated by Immunosuppressive Agents."
            }
        ], 
        "biospec_descr": {
            "textblock": "whole blood"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to analysis the different genotype in the idiopathic membranous\n      nephropathy patients which with different therapeutic outcomes after treated by the\n      Comprehensive Treatment Regimen or immunosuppressive agents, and so as to looking for ideal\n      markers to assess appropriate treatment approach and the long-term efficacy."
        }, 
        "brief_title": "Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy", 
        "completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Idiopathic Membranous Nephropathy", 
        "condition_browse": {
            "mesh_term": [
                "Glomerulonephritis, Membranous", 
                "Kidney Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "The primary objective of this study is to looking for the gene level predictors in the\n      patients who suffered from idiopathic membranous nephropathy. And according to the\n      predictors, the clinicians could make a decision which method should be taken on IMN\n      patients, Traditional Chinese Medicine or western medicine, and could get better results."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical diagnosis of idiopathic membranous nephropathy\n\n          -  Chronic Kidney Disease (CKD)\u22643 stage\uff08Glomerular Filtration Rate (GFR)\u226530ml/min\uff09and 24\n             hour urinary protein\u22653g\n\n          -  Voluntarily participated in the study and signed an informed consent\n\n        Exclusion Criteria:\n\n          -  Combined life-threatening complications such as serious infection\n\n          -  Abnormal glucose metabolism\n\n          -  Patients with malignant tumors or malignancy , HIV infection and a history of mental\n             illness , acute central nervous system disease , serious gastrointestinal\n             diseases,etc\n\n          -  Pregnancy or breast-feeding women\n\n          -  Undergoing other clinical trials"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "idiopathic membranous nephropathy"
            }
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01799460", 
            "org_study_id": "ShanghaiMEC-2011", 
            "secondary_id": "11YZ65"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "CR/CTR group", 
                    "NR/CTR group"
                ], 
                "description": "\u2460ShenQiMoShen Decoction: which plays vital therapeutic effect in the CTR,the dosage is 150ml per serving and two services per day.Dosage and administration:150ml per time,twice per day\n\u2461HuoXueTongMai Capsule : which plays a vital role of promoting blood circulation and removing blood stasis. Its main components are the leeches. Dosage and administration: 4 capsules 3 times daily.\n\u2462HeiLiaoDou Particle: which will be prescribed when hypoproteinemia (serum albumin concentration\u226430g/L)occurred and should be stopped taking until the serum albumin is above 30g/L. Dosage and administration: 2 packages 3 times daily.", 
                "intervention_name": "The Comprehensive Treatment Regimen of Traditional Chinese Medicine", 
                "intervention_type": "Drug", 
                "other_name": [
                    "ShenQiMoShen Decoction", 
                    "HuoXueTongMai Capsule", 
                    "HeiLiaoDou Particle"
                ]
            }, 
            {
                "arm_group_label": [
                    "CR/IA group", 
                    "NR/IA group"
                ], 
                "description": "According to Kidney  Disease Improving Global Outcomes (KDIGO) clinical practice guideline for glomerulonephritis", 
                "intervention_name": "The immunosuppressive agents", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Glucocorticoid", 
                    "Cyclosporine", 
                    "Cyclophosphamide", 
                    "Tacrolimus"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclophosphamide", 
                "Immunosuppressive Agents", 
                "Glucocorticoids"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "single-nucleotide-polymorphism", 
            "Traditional Chinese Medicine", 
            "the Comprehensive Treatment Regimen"
        ], 
        "lastchanged_date": "April 22, 2013", 
        "location": {
            "contact": {
                "email": "happytlynn@163.com", 
                "last_name": "Wang Lin, PHD", 
                "phone": "86-13816583673"
            }, 
            "facility": {
                "address": {
                    "city": "Shanghai", 
                    "country": "China", 
                    "state": "Shanghai", 
                    "zip": "200032"
                }, 
                "name": "Shanghai University of Traditional Chinese Medicine"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "4", 
        "official_title": "Mechanism Research of Traditional Chinese Medicine (the Comprehensive Treatment Regimen) in Treating Idiopathic Membranous Nephropathy by Genomewide Association Studies", 
        "overall_contact": {
            "email": "happytlynn@163.com", 
            "last_name": "Wang Lin, PHD", 
            "phone": "86-13816583673"
        }, 
        "overall_official": {
            "affiliation": "Shanghai University of Traditional Chinese Medicine", 
            "last_name": "Wang Lin, PHD,MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Screening for single-nucleotide-polymorphism as the prognostic factor for the TCM intervention of IMN patients.", 
            "measure": "Genome-wide single-nucleotide-polymorphism of IMN patients treated by the Comprehensive Treatment Regimen or conventional approach", 
            "safety_issue": "No", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01799460"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Shanghai University of Traditional Chinese Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shanghai University of Traditional Chinese Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2010", 
        "study_design": "Observational Model: Cohort, Time Perspective: Retrospective", 
        "study_type": "Observational", 
        "verification_date": "April 2013"
    }
}